Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: Mechanism for immune evasion?

This publication has 24 references indexed in Scilit:

• Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer
  World Journal of Gastrointestinal Oncology, 2010
• Expression Pattern of Immune Suppressive Cytokines and Growth Factors in Oesophageal Adenocarcinoma Reveal a Tumour Immune Escape‐promoting Microenvironment
  Scandinavian Journal of Immunology, 2008
• Lung Cancer
  New England Journal of Medicine, 2008
• The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells
  European Journal of Immunology, 2005
• Low Lung Function and Incident Lung Cancer in the United States
  Archives of internal medicine (1960), 2003
• Epidemiology of Lung Cancer*
  Chest, 2003
• Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
  Blood, 2002
• Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
  Proceedings of the National Academy of Sciences, 2001
• The Granzyme B Inhibitor, PI-9, Is Present in Endothelial and Mesothelial Cells, Suggesting That It Protects Bystander Cells during Immune Responses
  Cellular Immunology, 2001
• Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
  International Journal of Cancer, 1996